RT Journal Article SR Electronic T1 Red flags useful to screen for gastrointestinal and hepatic diseases in patients with shoulder pain: a scoping review protocol JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.03.23.21254088 DO 10.1101/2021.03.23.21254088 A1 A Roncone A1 F Fiorentino A1 D Pennella A1 F Maselli A1 F Brindisino A1 S Giagio YR 2021 UL http://medrxiv.org/content/early/2021/03/26/2021.03.23.21254088.abstract AB Shoulder pain (SP) is the third most common musculoskeletal disorder worldwide and its prevalence ranges from 5 to 47%.However, the clinical presentation of signs and symptoms may hide other serious conditions; the so-called Red Flags (RFs).For these reasons, clinicians dealing with neuro-musculoskeletal shoulder disorders should pay particular attention during the medical history and clinical examination screening and identifying signs that may cause probable referred symptoms.Considering the variety of clinical presentations of SP and the importance of the screening for referral, identifying and summarizing the possible gastrointestinal and hepatic diseases among these patients may give a comprehensive overview to the clinicians and consequently may improve the overall management.To the authors knowledge, there are no published studies on the topic and, in this context, a scoping review is strongly required and corresponded to the objectives of this project.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAuthors declare that no external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no IRB was needed for scoping reviewAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data referred to manuscript will be pubblished